AI MARKET SCANNING

$UPB

Upstream Bio Inc

United StatesUNITED STATES
FREE PREVIEW
AVG HISTORICAL GAP-1.97%
MAX GAP RECORD-10.93%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $UPB

EXECUTIONS0
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
RADAR SCANNING: WAITING FOR NEXT CATALYST
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY2.6%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR $UPB

AI REPORT
Jul 03

Deep Dive into Earnings Gap Anticipation with WIHL.ST

Analysis Markets are buzzing with anticipation as $WIHL.ST prepares to release its quarterly earnings report. Investors and traders…